ID: ALA4441499

Max Phase: Preclinical

Molecular Formula: C26H30N2O5

Molecular Weight: 450.54

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1CC[C@H]2[C@@](C)(CCC(=O)N[C@@]2(C)COC(=O)c2cccnc2)[C@@H]1/C=C/C1=CCOC1=O

Standard InChI:  InChI=1S/C26H30N2O5/c1-17-6-9-21-25(2,20(17)8-7-18-11-14-32-23(18)30)12-10-22(29)28-26(21,3)16-33-24(31)19-5-4-13-27-15-19/h4-5,7-8,11,13,15,20-21H,1,6,9-10,12,14,16H2,2-3H3,(H,28,29)/b8-7+/t20-,21+,25+,26+/m1/s1

Standard InChI Key:  YHNMVGRIQQOWBY-IHOZZYEOSA-N

Associated Targets(Human)

Hexokinase type II 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.54Molecular Weight (Monoisotopic): 450.2155AlogP: 3.54#Rotatable Bonds: 5
Polar Surface Area: 94.59Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.55CX Basic pKa: 3.24CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.54Np Likeness Score: 1.89

References

1. Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L..  (2019)  Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities.,  173  [PMID:31009914] [10.1016/j.ejmech.2019.04.022]

Source